Effects of HLA single chain trimer design on peptide presentation and stability.

HLA single-chain trimers X-ray crystallography human class I leukocyte antigens pan-anti-class I antibodies peptide presentation

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2023
Historique:
received: 20 02 2023
accepted: 21 04 2023
medline: 22 5 2023
pubmed: 19 5 2023
entrez: 19 5 2023
Statut: epublish

Résumé

MHC class I "

Identifiants

pubmed: 37207206
doi: 10.3389/fimmu.2023.1170462
pmc: PMC10189100
doi:

Substances chimiques

Histocompatibility Antigens Class I 0
Peptides 0
Epitopes 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1170462

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI176563
Pays : United States
Organisme : NIH HHS
ID : S10 OD028581
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA015704
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI121242
Pays : United States

Informations de copyright

Copyright © 2023 Finton, Rupert, Friend, Dinca, Lovelace, Buerger, Rusnac, Foote-McNabb, Chour, Heath, Campbell, Pierce and Strong.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Mol Biol. 2001 Aug 3;311(1):123-9
pubmed: 11469862
Nucleic Acids Res. 2000 Jan 1;28(1):235-42
pubmed: 10592235
J Immunol. 1979 Jul;123(1):342-9
pubmed: 87477
J Mol Biol. 2007 Sep 21;372(3):774-97
pubmed: 17681537
Annu Rev Biochem. 2013;82:775-97
pubmed: 23495938
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
pubmed: 15572765
Nat Protoc. 2006;1(2):755-68
pubmed: 17406305
J Mol Biol. 2001 Jun 8;309(3):657-70
pubmed: 11397087
J Immunol Methods. 2007 Jul 31;324(1-2):13-25
pubmed: 17568607
Annu Rev Immunol. 2006;24:419-66
pubmed: 16551255
Sci Immunol. 2019 Jul 19;4(37):
pubmed: 31324691
Protein Sci. 2018 Jan;27(1):293-315
pubmed: 29067766
J Immunol. 1994 Feb 1;152(3):1213-21
pubmed: 8301126
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):235-42
pubmed: 21460441
Nucleic Acids Res. 2015 Jan;43(Database issue):D432-8
pubmed: 25392411
Science. 1996 Oct 4;274(5284):94-6
pubmed: 8810254
Trends Immunol. 2016 Nov;37(11):724-737
pubmed: 27614798
BMC Bioinformatics. 2019 Jul 3;20(Suppl 14):335
pubmed: 31266447
Chem Biol. 2007 Aug;14(8):909-22
pubmed: 17719490
Sci Transl Med. 2013 Mar 13;5(176):176ra33
pubmed: 23486779
J Biol Chem. 2013 May 31;288(22):15442-54
pubmed: 23569211
J Immunol. 2002 Apr 1;168(7):3145-9
pubmed: 11907065
Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):12-21
pubmed: 20057044
Acta Crystallogr D Biol Crystallogr. 1997 May 1;53(Pt 3):240-55
pubmed: 15299926
Nucleic Acids Res. 2007 Jul;35(Web Server issue):W375-83
pubmed: 17452350
Front Immunol. 2021 Apr 23;12:658372
pubmed: 33986749
J Cell Sci. 2014 Jul 1;127(Pt 13):2885-97
pubmed: 24806963
Mol Immunol. 2000 Aug;37(10):579-90
pubmed: 11163394
Sci Immunol. 2019 Jul 19;4(37):
pubmed: 31324690
Cell. 1978 May;14(1):9-20
pubmed: 667938
J Biol Chem. 2003 Jul 18;278(29):27105-11
pubmed: 12732632
Protein Sci. 1998 May;7(5):1264-6
pubmed: 9605335
J Immunol. 2000 Jun 15;164(12):6398-405
pubmed: 10843695
J Immunol. 2007 May 15;178(10):6280-9
pubmed: 17475856
Protein Eng Des Sel. 2010 Apr;23(4):155-9
pubmed: 20130105
PLoS Pathog. 2014 Sep 25;10(9):e1004403
pubmed: 25254371
J Immunol. 1995 Jun 1;154(11):5934-43
pubmed: 7538538
J Immunol Methods. 2016 May;432:95-101
pubmed: 26906089
Mol Ther Methods Clin Dev. 2014 Jul 02;1:14027
pubmed: 26015969
Trends Immunol. 2010 Oct;31(10):363-9
pubmed: 20832361
Acta Crystallogr D Biol Crystallogr. 2003 Jul;59(Pt 7):1131-7
pubmed: 12832755
J Immunol. 2001 Sep 15;167(6):3276-84
pubmed: 11544315
Immunol Rev. 2012 Nov;250(1):239-57
pubmed: 23046134
Acta Crystallogr D Struct Biol. 2017 Feb 1;73(Pt 2):148-157
pubmed: 28177311
Acta Crystallogr D Struct Biol. 2019 Oct 1;75(Pt 10):861-877
pubmed: 31588918
Acta Crystallogr D Biol Crystallogr. 2002 Nov;58(Pt 11):1948-54
pubmed: 12393927
Oncoimmunology. 2015 Jun 1;5(1):e1049803
pubmed: 26942058
J Biol Chem. 2003 Feb 14;278(7):5082-90
pubmed: 12411439
Nucleic Acids Res. 2011 Nov;39(21):e143
pubmed: 21911364

Auteurs

Kathryn A K Finton (KAK)

Division of Basic Science, Fred Hutchinson Cancer Research Center (FHCC), Seattle, WA, United States.

Peter B Rupert (PB)

Division of Basic Science, Fred Hutchinson Cancer Research Center (FHCC), Seattle, WA, United States.

Della J Friend (DJ)

Division of Basic Science, Fred Hutchinson Cancer Research Center (FHCC), Seattle, WA, United States.

Ana Dinca (A)

Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.

Erica S Lovelace (ES)

Division of Basic Science, Fred Hutchinson Cancer Research Center (FHCC), Seattle, WA, United States.

Matthew Buerger (M)

Division of Basic Science, Fred Hutchinson Cancer Research Center (FHCC), Seattle, WA, United States.

Domnita V Rusnac (DV)

Division of Basic Science, Fred Hutchinson Cancer Research Center (FHCC), Seattle, WA, United States.

Ulysses Foote-McNabb (U)

Division of Basic Science, Fred Hutchinson Cancer Research Center (FHCC), Seattle, WA, United States.

William Chour (W)

Institute for Systems Biology, Seattle, WA, United States.

James R Heath (JR)

Institute for Systems Biology, Seattle, WA, United States.

Jean S Campbell (JS)

Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.

Robert H Pierce (RH)

Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.

Roland K Strong (RK)

Division of Basic Science, Fred Hutchinson Cancer Research Center (FHCC), Seattle, WA, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH